Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Not yet recruiting × Dasatinib × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Unknown 2 Recruiting 2 Completed 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

anlotinib 5 Carboplatin 5 lenvatinib 4 Oxaliplatin 4 Cisplatin 4 sintilimab 3 Prednisone 3 Immune Checkpoint Inhibitors 3 Dexmedetomidine 3 Dexamethasone 3 venetoclax 2 tislelizumab 2 lorlatinib 2 Rosuvastatin Calcium 2 Leucovorin 2 Injections 2 Indocyanine Green 2 Fluorouracil 2 Drug Therapy 2 Cyclophosphamide 2 Capecitabine 2 Bevacizumab 2 Aspirin 2 zanubrutinib 1 xiaojin wan 1 trastuzumab deruxtecan 1 trametinib 1 testosterone 17 beta-cypionate 1 tenofovir alafenamide 1 telitacicept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡